Sacituzumab govitecan: a promising antibody-drug conjugate for the treatment of poorly differentiated endometrial cancer.

ABSTRACT:

SUBMITTER: Webster EM 

PROVIDER: S-EPMC7640901 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature